A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma

Singh, D; Fuhr, R; Bird, NP; Mole, S; Hardes, K; Man, YL; Cahn, A; Yancey, SW; Pouliquen, IJ

Bird, NP (通讯作者)，GSK, Biostat, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022; 88 (2): 702

Abstract

Aims GSK3511294 is a humanized anti-interleukin (IL)-5 monoclonal antibody (mAb) engineered for extended half-life and improved IL-5 affinity versus o......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索